AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇷🇼
Lenacapavir Sodium in Rwanda
2 products registered with RDA — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Lenacapavir Gilead 464 mg solution for injection Solution for Injection. | RWANDA-FDA25/HM/0617/0043 | Patheon Italia S.p.A. | active | 11 Dec 2030 |
| Lenacapavir Gilead 300 mg film-coated tablets TABLES | RWANDA-FDA25/HM/0620/0042 | ROTTENDORF PHARMA GMBH | active | 11 Dec 2030 |
Lenacapavir Sodium — RDA Registration Details
RDA (Rwanda) has 2 registered products containing Lenacapavir Sodium, of which 2 are currently active. Data is sourced directly from the official RDA drug register and refreshed daily.
Track Lenacapavir Sodium registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.